$KEY

BANK OF NOVA SCOTIA sold (to issuer) $5.5M of KEY

BANK OF NOVA SCOTIA sold (to issuer) 238,461 shares of KEYCORP /NEW/ (KEY) at $23.15 ($5.52M total) on 2026-06-30.

Original reporting
SEC EDGAR · BANK OF NOVA SCOTIA
Published Jun 30, 2026, 10:23 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jun 30, 2026, 10:27 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$KEY
Neutral
medium confidence
Mentioned
$KEY
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$KEYNeutralLow
01

Why it matters

The newest disclosed fact is the sale-to-issuer of 238,461 shares at $23.15 ($5.52M total) on 2026-06-30, which may slightly influence sentiment but does not change company fundamentals based on the provided text.

02

Market read

A single Form 4 sale-to-issuer transaction for KEY; potential minor sentiment impact, but no new fundamental catalyst in the text.

03

What to watch

The filing does not state a 10b5-1 plan and does not provide intent; traders should avoid over-weighting this as a directional signal without corroborating news.

Relevance 6/10Novelty 3/10Timing: SEC Form 4 filed 2026-06-30 (after-hours) for KEY insider sale-to-issuer.

Background

The article is an SEC Form 4 insider transaction disclosure for KEYCORP /NEW/ (KEY), reported by Bank of Nova Scotia as a director/10% owner role.

Company-level read

Ticker impact

$KEYNeutralMedium confidence
Context

Bank of Nova Scotia reported a Form 4 sale-to-issuer of 238,461 KEY shares at $23.15 on 2026-06-30.

Expected impact

Likely limited immediate price impact; any effect would be sentiment-driven and small versus fundamentals.

Evidence & confidence

Form 4 insider sales can affect sentiment, but the filing is a sale-to-issuer code (often tied to issuer programs) and provides no new operating/regulatory catalyst.

Market effects

Minimal read-through to the broader financial sector; this is a single-company insider transaction.

None indicated; filing is US SEC EDGAR with no regional policy or macro linkage.

Low; no cross-border deal, regulation, or systemic risk described.

Counterpoint

Because the transaction is coded as sale-to-issuer, it may reflect mechanical participation in an issuer process rather than a bearish view on KEY.

Key entities

  • KEYCORP /NEW/

    Issuer of the Form 4 insider transaction; shares sold to issuer on 2026-06-30.

  • Bank of Nova Scotia

    Reporter of the Form 4 transaction as director/10% owner; sold 238,461 shares to issuer.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$JPMMed

Major U.S. banks raise prime rate after Fed rate hike

Major U.S. banks, including JPMorgan, Bank of America, and others, raised their prime lending rate to 7% after the Federal Reserve's quarter-point rate hike. The move increases borrowing costs for consumers and businesses. Bank stocks fell, with BofA down 2.7%, Citi 2.4%, and JPMorgan 1%. Rate hikes may boost bank earnings but could also slow economic activity and impact credit quality.

$JPMMed

Major US banks raise prime rate after first Fed rate hike since 2023

Top U.S. banks, including JPMorgan and Bank of America, raised their prime lending rate to 7% after the Federal Reserve's first rate hike since 2023. The Fed increased rates by 0.25% and signaled further hikes, aiming to combat inflation. Bank shares fell, with JPMorgan down 1% and Goldman Sachs down 4%. Higher rates boost bank earnings but may slow economic activity and reduce loan demand.

$KEYMed

KeyCorp Raises 2026 Revenue Outlook: What's Driving It?

KeyCorp (KEY) raised its 2026 revenue outlook to 8% growth, up from 7-8%, citing strong loan growth, fee-based business momentum, and the Clearwater acquisition. Non-interest income is now expected to grow 4-5%, with adjusted non-interest income projected to increase 6-7%. The company also affirmed a 20%+ sequential rise in third-quarter investment-banking fees. KeyCorp anticipates 4-5% average loan growth and 9-11% net interest income growth for 2026, supported by solid loan demand and deposit

$KEYMedAI 8/10

FCA clears acquisition of Clearwater UK by KeyCorp

The UK Financial Conduct Authority cleared KeyCorp’s acquisition of corporate finance advisory firm Clearwater UK. KeyCorp completed the deal on 4 August 2026 and notified investors on the New York Stock Exchange. The article says Clearwater UK will use KeyCorp’s expertise for corporate finance advisory services.

$KEYMed

KeyCorp Q2 2026 Earnings Call Summary

KeyCorp’s Q2 2026 earnings call cited 3% sequential commercial loan growth, net interest margin expansion to 2.89%, and 12% growth in commercial payments fees. Management raised full-year revenue guidance to 7-8% growth and projected NIM of 3.0% to 3.05% by year-end, plus $1.3B+ in 2026 buybacks.